In order to assess the possibility of phosphorylation-independent involvement of eIF4E, HCC cells and immortalized hepatocytes were treated for 72 hours with siRNA targeting eIF4E and S6K. The gene discussed is EIF4E; the disease is hepatocellular carcinoma.